Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics


Arrowhead Pharmaceuticals, Inc. (ARWR)

Today's Latest Price: $82.15 USD

1.41 (1.75%)

Updated Jan 19 4:00pm

Add ARWR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 483 in Biotech

See all "A" rated Strong Buy stocks

ARWR Stock Summary

  • With a price/sales ratio of 93.94, Arrowhead Pharmaceuticals Inc has a higher such ratio than 96.31% of stocks in our set.
  • Over the past twelve months, ARWR has reported earnings growth of -253.2%, putting it ahead of only 7.83% of US stocks in our set.
  • As for revenue growth, note that ARWR's revenue has grown -47.87% over the past 12 months; that beats the revenue growth of just 5.85% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Arrowhead Pharmaceuticals Inc are ARVN, CUE, ZYME, FGEN, and CCXI.
  • ARWR's SEC filings can be seen here. And to visit Arrowhead Pharmaceuticals Inc's official web site, go to arrowheadpharma.com.

ARWR Stock Price Chart Interactive Chart >

Price chart for ARWR

ARWR Price/Volume Stats

Current price $82.15 52-week high $86.75
Prev. close $80.74 52-week low $19.51
Day low $80.61 Volume 538,500
Day high $83.45 Avg. volume 895,064
50-day MA $72.94 Dividend yield N/A
200-day MA $49.48 Market Cap 8.44B

Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio


Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.


ARWR Latest News Stream


Event/Time News Detail
Loading, please wait...

ARWR Latest Social Stream


Loading social stream, please wait...

View Full ARWR Social Stream

Latest ARWR News From Around the Web

Below are the latest news stories about Arrowhead Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARWR as an investment opportunity.

How Arrowhead Protects Its Intellectual Property

Happy New Year to all my readers! Some companies that are R&D powerhouses spend years doing pioneering research in biotechnology. While that is good for the progress of medicine, financially, your medicine is only as good as its patent coverage. Arrowhead (ARWR) is such an R&D behemoth in the RNAi...

Avisol Capital Partners on Seeking Alpha | December 30, 2020

Is ARWR A Good Stock To Buy Now According To Hedge Funds?

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

Yahoo | December 20, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Business Wire | December 7, 2020

ARWR: Update on Cardiometabolic Candidates…

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Cardiometabolic Programs Offer Enormous Potential In November 2020, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) hosted KOL events for its lead cardiometabolic programs, ARO-APOC3 and ARO-ANG3. The company had previously announced encouraging results for each of those programs (see our previous update here ) and

Yahoo | December 7, 2020

New Forecasts: Here's What Analysts Think The Future Holds For Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Celebrations may be in order for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders, with the analysts...

Yahoo | November 28, 2020

Read More 'ARWR' Stories Here

ARWR Price Returns

1-mo 2.48%
3-mo 44.83%
6-mo 76.06%
1-year N/A
3-year 1,206.04%
5-year 1,953.75%
YTD 7.06%
2020 20.97%
2019 410.71%
2018 237.50%
2017 137.42%
2016 -74.80%

Continue Researching ARWR

Here are a few links from around the web to help you further your research on Arrowhead Pharmaceuticals Inc's stock as an investment opportunity:

Arrowhead Pharmaceuticals Inc (ARWR) Stock Price | Nasdaq
Arrowhead Pharmaceuticals Inc (ARWR) Stock Quote, History and News - Yahoo Finance
Arrowhead Pharmaceuticals Inc (ARWR) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.696 seconds.